which company makes semaglutide FDA Warns on Certain Forms of Compounded Semaglutide GLP-1 Receptor Agonist Research

Poor sleep, which can increase cravings and lower impulse control

Report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch

Regular glucose monitoring and dose adjustments are necessary to stabilize blood sugar levels when these drugs are co-administered

Pharmacists serve as an additional resource for identifying potential interactions and can provide guidance on optimal medication timing strategies

In some cases, adjusting the dosage or timing of administration may help alleviate these symptoms

Often, when patients start a GLP-1 medication, they are surprised that certain foods can cause significant side effects, says Meghan Garcia-Webb, MD, a board-certified internal, lifestyle, and obesity medicine physician in private practice in Wellesley, Massachusetts